In another study of diabetic kidney disease, sodium-glucose cotransporter 2 inhibition could suppress HIF-1α-mediated metabolic switch from lipid oxidation to glycolysis and exert a kidney protective effect (31). This evidence concerns the gene SLC5A2 and diabetic kidney disease.